Pauli G, Metz-Favre C
Université de strasbourg, hôpital Civil, bâtiment ancienne ophtalmologie, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France.
Rev Mal Respir. 2013 Apr;30(4):328-37. doi: 10.1016/j.rmr.2012.10.633. Epub 2013 Jan 23.
The association of food allergies and pollinosis are numerous, implicating tree, grass and weed pollens on one hand and on the other, several plant foods which after ingestion can induce an oral syndrome or more severe reactions such as urticaria, Quincke's edema, asthma and even anaphylactic shock.
The molecular basis of cross reactions between pollens and vegetable food allergens is increasingly understood. The principal allergens involved are those of the Bet v 1 family, and profilins found in all pollens as well as in many fruits and vegetables; these two groups of allergens are denatured by high temperatures and by gastric enzymes, in contrast to LTP, which is only found in weeds and some tree pollens. Other molecules can be involved in cross reactions such as Bet v 6 (an isoflavone reductase), 1 beta glucanases and thaumatine-like proteins. Inhibition experiments confirmed that the epitopes responsible for primary sensitization come mainly from pollen allergens; the cross-reactive molecular allergen is related to the geographic environment of the patients.
The practical aspects of managing these patients are underlined: explanations of co-sensitization, explanations for the lack of efficacy of some extracts, usefulness of a molecular diagnosis obtained either by CAP or microarray, prediction of severe clinical reactions induced by specific molecular allergens and the effectiveness of pollen immunotherapy on the cross-related food allergy.
食物过敏与花粉症之间存在诸多关联,一方面涉及树木、草类和杂草花粉,另一方面涉及多种植物性食物,这些食物在摄入后可引发口腔综合征或更严重的反应,如荨麻疹、昆克水肿、哮喘甚至过敏性休克。
花粉与植物性食物过敏原之间交叉反应的分子基础日益明晰。主要涉及的过敏原是Bet v 1家族的过敏原以及在所有花粉以及许多水果和蔬菜中发现的肌动蛋白;与仅在杂草和一些树木花粉中发现的脂质转移蛋白(LTP)不同,这两类过敏原会被高温和胃酶变性。其他分子也可能参与交叉反应,如Bet v 6(一种异黄酮还原酶)、1β - 葡聚糖酶和类甜蛋白。抑制实验证实,引发初次致敏的表位主要来自花粉过敏原;交叉反应性分子过敏原与患者的地理环境有关。
强调了管理这些患者的实际方面:对共同致敏的解释、对某些提取物缺乏疗效的解释、通过CAP或微阵列获得的分子诊断的有用性、对特定分子过敏原引发严重临床反应的预测以及花粉免疫疗法对交叉相关食物过敏的有效性。